Pharmocann Global Balance Sheet Health
Finanzielle Gesundheit Kriterienprüfungen 3/6
Pharmocann Global has a total shareholder equity of ₪223.0K and total debt of ₪0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are ₪2.2M and ₪2.0M respectively.
Wichtige Informationen
0%
Verhältnis von Schulden zu Eigenkapital
₪0
Verschuldung
| Zinsdeckungsgrad | n/a |
| Bargeld | ₪612.00k |
| Eigenkapital | ₪223.00k |
| Gesamtverbindlichkeiten | ₪1.95m |
| Gesamtvermögen | ₪2.18m |
Jüngste Berichte zur Finanzlage
Keine Aktualisierungen
Recent updates
The Returns On Capital At Pharmocann Global (TLV:PMCN) Don't Inspire Confidence
Mar 30
Should You Use Pharmocann Global's (TLV:PMCN) Statutory Earnings To Analyse It?
Feb 04Pharmocann Global Ltd (TLV:PMCN) Stock's Been Sliding But Fundamentals Look Decent: Will The Market Correct The Share Price In The Future?
Dec 31
The Returns At Pharmocann Global (TLV:PMCN) Provide Us With Signs Of What's To Come
Nov 26Analyse der Finanzlage
Kurzfristige Verbindlichkeiten: PMCN-M's short term assets (₪1.1M) do not cover its short term liabilities (₪1.8M).
Langfristige Verbindlichkeiten: PMCN-M's short term assets (₪1.1M) exceed its long term liabilities (₪151.0K).
Geschichte und Analyse des Verhältnisses von Schulden zu Eigenkapital
Verschuldungsgrad: PMCN-M is debt free.
Schulden abbauen: PMCN-M has no debt compared to 5 years ago when its debt to equity ratio was 0.7%.
Bilanz
Liquiditätsreserve-Analyse
Bei Unternehmen, die in der Vergangenheit im Durchschnitt Verluste gemacht haben, wird geprüft, ob sie über einen Liquiditätsvorlauf von mindestens einem Jahr verfügen.
Stabile Start- und Landebahn für Bargeld: PMCN-M has less than a year of cash runway based on its current free cash flow.
Vorhersage Cash Runway: PMCN-M has less than a year of cash runway if free cash flow continues to reduce at historical rates of 34.9% each year